BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
Bon Natural Life Ltd
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026
$1.12−0.02 (-1.51%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Bon Natural Life Ltd revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Fragrance Compounds [Member] | $8.08M | $4.94M | $14.32M | $13.71M | $12.74M | $7.88M | $6.74M | 43.3% | +63.5% |
| Bioactive Food Ingredients [Member] | $7.26M | $12.16M | $6.50M | $9.05M | $6.09M | $6.45M | $5.32M | 38.9% | -40.3% |
| Health Supplements (Solid Drinks) [Member] | $3.33M | $6.74M | $8.70M | $7.15M | $6.66M | $3.89M | $4.34M | 17.8% | -50.6% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| PRC [Member] | – | – | – | $28.76M | $23.70M | $15.46M | $11.19M | – | – |
| Overseas [Member] | – | $301.69K | $551.24K | $1.15M | $1.79M | $2.76M | $5.20M | – | – |
| China | – | $23.54M | $28.97M | $28.76M | $23.70M | – | – | – | – |
From the segment and revenue-disaggregation notes of Bon Natural Life's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.